Abstract:We thank Cao et al. [1] for their insightful comments on our manuscript recently published in the European Journal of CardioThoracic Surgery [2]. Cao et al. addressed, in their letter to the editor, two important and controversial aspects of segmentectomy comparing with lobectomy for early stage non-small-cell lung cancer (NSCLC), which we would like to discuss in detail. The first issue emphasized by Cao et al. was the rationality of using combined overall survival (OS) and cancer-specific survival (CSS) outcomes to compare the two different surgical procedures. Our study aimed at assessing the survival difference between segmentectomy and lobectomy. We must admit that combining OS and CSS does have some shortcomings such as it may overestimate the adverse survival outcomes of segmentectomy procedures just as Cao et al. pointed out. However, the data we based our study on were divergent, with few providing CSS, whereas most of the published studies use OS to assess the two procedures. The overestimation exists in each published study which selected the patients with limited cardiopulmonary function as candidates for segmentectomy; it is inevitable for us to avoid such overestimation. Besides, a previously published paper also used combined OS and CSS to assess oncological outcomes [3]. It is insufficient to conduct meta-analysis for the comparison of segmentectomy and lobectomy exclusively based on either OS or CSS data and it would be possible in future to conduct such a meta-analysis with subgroups of OS and CSS as new suitable data are published. The other issue proposed by Cao et al. is to differentiate the intentional segmentectomy from the compromised one; recently, several studies also excluded compromised segmentectomy and aimed to compare intentional segmentectomy with lobectomy [4, 5]. Some studies, such as Tsutani et al. [6], reported the use of propensity score analysis. We agree with Cao et al. that these studies would be the future direction. However, as the data are insufficient, it is still meaningful to estimate the oncological effects of segmentectomy including both compromised and intentional procedures. We are also undertaking a prospective study aimed at selecting the optimal candidates for intentional segmentectomy. The issue that segmentectomy, especially the intentional one, or lobectomy, which is suitable for early stage NSCLC, would be long-existing until the future randomized controlled trials such as CALGB 140503 and JCOG 0802. We are grateful to Cao et al. [1] for their kind and insightful comments, and we thank them for taking the time to remark on our work.

In reply to the letter to the editor regarding "Clinical outcomes of teeth adjacent to the site of mandibulotomy or mandibulectomy in patients with head and neck cancer: results from a multidisciplinary mono-institutional head and neck tumor board"

In Reply to Abbasi Et Al

In regard to Castagnola et al. (doi: 10.1186/s12903-023-03050-7)

Reply to Cao Et Al.

Reply to Wei Qi's letter to the editor about "Preoperative proteinuria correlates with renal function after partial nephrectomy for renal cell carcinoma"

Letter to the editor regarding, "Impact of post-operative transoral robotic surgery hemorrhage on adjuvant treatment delays in patients with oropharyngeal squamous cell carcinoma"

Reply to Sonnenberg et al

Letter to the editor regarding "Surgical management of naso-orbito-ethmoidal fractures: a systematic review"

Reply to Pouw Et Al.

The Effect of Conservative vs. Radical Treatment of Ameloblastoma on Recurrence Rate and Quality of Life: An Umbrella Review

Correction: Mazzini et al. Anatomical and Functional Outcomes after Endoresection and Adjuvant Ruthenium Brachytherapy for Uveal Melanoma: A Single-Center Experience. Life 2023, 13, 902

Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma

[Corrigendum] Jak3 is involved in CCR7‐dependent migration and invasion in metastatic squamous cell carcinoma of the head and neck

Where Do We Stand? Results from an Italian Multicentric Prospective Database. J. Clin. Med. 2024, 13, 3106"

Periodontal disease-like bone loss after adjuvant radiotherapy in the head and neck region: A case report and review of the literature

Oral malignant and potentially malignant lesions after allogenic hematopoietic cell transplantation: a 10-year follow-up study

[Concurrent simultaneous integrated boost radiotherapy and cetuximab in head and neck squamous cell cancer patients: is it feasible in daily clinical practice?]

Temporomandibular Disorders: Improving Outcomes Using A Multidisciplinary Approach [Erratum]

Response to Comment on Associations Between Preoperative Inspiratory Muscle Training Variables and Postoperative Pulmonary Complications in Subjects With Esophageal Cancer

Endoscopic transorbital and transcranial multiportal resection of a sphenoorbital meningiomas with custom bone 3D printing reconstruction: Case report

Reply to Itagaki et al. Comment on "Dorobisz et al. Assessment of Prognostic Factors, Clinical Features Including the Microbiome, and Treatment Outcomes in Patients with Cancer of Unknown Primary Site. Cancers 2024, 16, 3416"